Trial ID or NCT#

NCT03137472

Status

RECRUITING

Purpose

The aim of the current study is to assess the efficacy of TMS in the treatment of Complex Regional Pain Syndrome (CRPS). It is hypothesized that participants who receive TMS (Group 1) relative to sham treatment (Group 2) once daily for two days will demonstrate a greater improvement in CRPS-related pain and other associated symptomology (i.e., cognitive, emotional and physical) compared to baseline. Participants will be followed until they reach their baseline for two consecutive weeks to assess safety and duration of symptom alleviation.

Official Title

Transcranial Magnetic Stimulation (TMS) for Complex Regional Pain Syndrome (CRPS)

Eligibility Criteria

Ages Eligible for Study: 18 Years to 70 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Sean Mackey, M.D., Ph.D.
Pain management specialist, Anesthesiologist
Redlich Professor, Professor of Anesthesiology, Perioperative, and Pain Medicine and, by courtesy, of Neurology at the Stanford University Medical Center

Contact us to find out if this trial is right for you.

CONTACT

Kristen H Scherrer
(650) 724-2091